BioHealth News
Northwest Biotherapeutics Announces Exclusive In-License of Portfolio of Dendritic Cell Technology and Intellectual Property
BETHESDA, Md., June 17, 2024 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that…
Read More
Ascentage Pharma Signs Option Agreement with Takeda to Enter into Exclusive Global License for Olverembatinib, a Third-Generation BCR-ABL Tyrosine Kinase Inhibitor (TKI)
ROCKVILLE, Md. and SUZHOU, China, June 14, 2024 /PRNewswire/ -- Ascentage Pharma (6855 HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B…
Read More
Leading the Charge in Tech-Based Economic Development: A Conversation with Dan Berglund of SSTI on BioTalk
Join us for an enlightening episode of BioTalk with Rich Bendis as we welcome Dan Berglund, President and CEO of SSTI. With nearly four…
Read More
Seraxis Wins Maryland Stem Cell Research Fund Grant to Accelerate Development of Allogenetically Compatible Pancreatic Islet Replacement Therapy for Functional Cure of T1D
GERMANTOWN, MD / ACCESSWIRE / June 14, 2024 / Seraxis, Inc., a regenerative medicine company developing pancreatic islet replacement therapies to transform the lives of…
Read More
Novavax Submits Application to U.S. FDA for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine
GAITHERSBURG, Md., June 14, 2024/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that it has submitted an…
Read More
Vanda Pharmaceuticals Confirms Receipt of Revised Unsolicited Takeover Proposal from Future Pak
WASHINGTON, June 13, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. ("Vanda" or the "Company") (Nasdaq: VNDA) today confirmed that it has received a revised unsolicited proposal from Future…
Read More
TEDCO’s Maryland Innovation Initiative Announces Kulshreshtha as the New Executive Director
COLUMBIA, Md., (June 13, 2024) — The Maryland Innovation Initiative (MII) Board of Directors announces the appointment of Abishek Kulshreshtha as the executive director…
Read More
KeViRx, Inc. Awarded $1.99 Million to Advance Small Molecule Technology for Acute Lung Injury
CHARLOTTESVILLE, VA / ACCESSWIRE / June 11, 2024 / KeViRx, Inc., an innovative, early-stage pharmaceutical company, announced today the receipt of $1.99 million in grant funding from…
Read More
Program Updates Unveiled for TEDCO’s Maryland Innovation Initiative
COLUMBIA, Md., (June 11, 2024) — Program Updates Unveiled for TEDCO’s Maryland Innovation Initiative TEDCO, Maryland’s economic engine for technology companies, announced recent changes…
Read More
REGENXBIO Announces Leadership Transition
ROCKVILLE, Md., June 12, 2024 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that Curran Simpson, Chief Operating Officer, has been appointed as President, Chief Executive Officer and a…
Read More
TEDCO Invests in Kubanda Cryotherapy
Biotechnology company innovates treatment for pets with lumps, bumps and cancer COLUMBIA, Md., (June 11, 2024) — TEDCO, Maryland’s economic engine for technology companies,…
Read More
Linshom Medical Picked by TechConnect as Finalist in the Medical Threat Challenge
BALTIMORE, MD, US, June 10, 2024 /EINPresswire.com/ -- Linshom Medical, a start-up medical device company was selected to present at the TechConnect World Innovation Conference…
Read More
IGC Pharma Publishes Study in European Society of Medicine Investigating the Impact of CYP2C9 Genetic Polymorphism on Pharmacokinetics of Delta 9 Tetrahydrocannabinol
-- Study Deepens Understanding of Treatments for Alzheimer’s Patients, Enabling More Effective Treatments -- POTOMAC, Md.--(June 10, 2024)--IGC Pharma, Inc. (NYSE American: IGC) (“IGC” or…
Read More
HyperSpectral Announces $8.5M Series A Funding to Accelerate Deployment of Spectral Artificial Intelligence Software
Company Focused on Bringing Industry-Leading Technology to Market in Food Safety and MedTech Industries ALEXANDRIA, Va., June 5, 2024 /PRNewswire/ -- HyperSpectral, the world's first AI-powered spectral…
Read More
US FDA approves expanded age indication for GSK’s Arexvy, the first respiratory syncytial virus (RSV) vaccine for adults aged 50-59 at increased risk
PHILADELPHIA, June 07, 2024--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved AREXVY (Respiratory Syncytial Virus…
Read More